Saltsjo-Boo, Sweden

Birgitta Kristina Gotthammar


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Saltsjo-Boo, SE (1996 - 1997)
  • Stockholm, SE (1997 - 1999)

Company Filing History:


Years Active: 1996-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Birgitta Kristina Gotthammar

Introduction

Birgitta Kristina Gotthammar is a notable inventor based in Saltsjö-Boo, Sweden, recognized for her contributions to the field of organic chemistry. With a total of four patents to her name, Gotthammar has made significant advancements, particularly in the development of novel compounds with potential pharmaceutical applications.

Latest Patents

Among her latest innovations is a patent titled "Hydroxylated anthranilic acid derivatives." This invention covers novel derivatives of 3-hydroxyanthranilic acid (3-HANA), characterized by a complex general formula. The compounds consist of various functional groups chosen from alkyl, aryl, halogens, and other components, making them versatile for pharmaceutical formulations. The patent outlines methods for synthesizing these derivatives and describes their potential use in inhibiting the enzyme 3-hydroxy-anthranilate oxygenase, which is implicated in producing the neurotoxin quinolinic acid (QUIN). This groundbreaking work could lead to important therapeutic advancements.

Career Highlights

Birgitta has built a solid career through her work with prominent institutions. She has collaborated with the University System of Maryland and Astra Aktiebolag, both of which have allowed her to explore innovative research avenues and apply her findings in practical settings. Her patents reflect her deep understanding of chemical compounds and their applications within the pharmaceutical industry.

Collaborations

Throughout her career, Gotthammar has worked closely with esteemed colleagues, including Susanna Karin Björk and Mats Torbjörn Linderberg. These collaborations have fostered an environment of innovation and mutual support, enhancing the overall impact of their research endeavors.

Conclusion

Birgitta Kristina Gotthammar’s impressive portfolio of patents underscores her talent and dedication to advancing science through innovation. Her latest work shows significant potential for improving healthcare outcomes by targeting critical pathways in neurotoxicity. As she continues her work in the field, her contributions will undoubtedly shape the landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…